EN

cart
Menu
Client area
Log out
Menu

Events and news

Blog
Home > Blog > Regulatory Affairs

Accessing the European Pharma Market: becoming a MAH through dossier adaptation (II)

The European pharma market is becoming more competitive and accessible through its effort to adopt globally acknowledged standards and requirements, it is not surprising the increasing interest of investors to this appealing market.

When a non-European company is considering investing in EU business opportunities different strategies may be implemented depending on the company needs. One of these possible strategies is becoming a MAH through dossier adaptation.

This option is recommended for Non-EU companies looking to adapt their own dossiers in order to be able to commercialise their own products in Europe through the adaptation of their manufacturing processes and facilities.

The dossier or multiple dossier must comply with European requirements and a bioequivalence study must be presented along with all the adapted documentation. An inspection must be carried out and once approved the company will be granted of a European MAH status. Once the company becomes a MAH is allowed to market their registered products along the European Union.

Deep local knowledge is crucial when a company is considering accessing this market to ensure a cost-effectiveness strategy and minimize time landing in EU.

At Azierta, we provide global support for accessing the European Pharma Market to Non-European companies. We are experts in Regulatory Affairs, Compliance and EU Requirements Related Services. For further information, please visit our website European Market Access Support Services, do not hesitate to contact us in case of any doubt.

Back

Related posts

Accessing the European Pharma Market: becoming a MAH through...

Positioned as the second largest pharmaceutical market in the world and showing a steady and extensive growth pattern, Europe’s...

Read more

Biotechnology: Incentives of the Advanced Medicinal Products...

What are Advanced Therapies? Advanced-therapy medicines are medicines that are made from genes and cells. They may offer...

Read more

Líderes del sector farma & salud

100 professionals

Over 100 professionals

500 clients

Over 500 clients

9 year experience

9 years of experience

Innovation

Leading innovation

Client oriented

100% client oriented

We are at your complete disposal for any inquiry

Thank you for getting in touch! We will contact you as soon as possible to help you out
There has been an error while submitting your form, please try again, or call us at 912 77 10 76
Schedule appointment

Schedule a video call with our field experts

schedule

Offices

España

Madrid (HQ)

Vía de las Dos Castillas 33, Edificio 7 - 28224 Pozuelo de Alarcón (Madrid)

912 77 10 76

info@azierta.com

España

Barcelona

Ctra. de l'Hospitalet, 147, Edificio Roma - 08940 Barcelona

912 77 10 76

info@azierta.com

Colombia

Bogotá

Calle 25 nº 68-35

(+57) 3103498206

info@azierta.com

Portugal

Lisbon

Avenida da Liberdade, 10

(+34) 91 277 10 76

info@azierta.com

Italy

Milan

Bastioni di Porta Nuova, 21 - 20121 Milan

(+34) 91 277 10 76

info@azierta.com

France

Paris

54 rue de Londres - 75008 Paris

(+33) 180 209 978

info@azierta.com

We use "cookies" to improve your experience on our site. Cookies enable us to tailor messages and display ads to your interests. They also help us understand how our site is being used. By continuing to use our site you consent to use our cookies.